Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pseudomyxoma Peritonei × Tacrolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 102 Myelodysplastic Syndromes 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Leukemia 71 Hodgkin Disease 67 Lymphoma, Non-Hodgkin 64 Multiple Myeloma 63 Lymphoma 63 Leukemia, Lymphocytic, Chronic, B-Cell 62 Myeloproliferative Disorders 46 Graft vs Host Disease 46 Lymphoma, Follicular 44 Leukemia, Myeloid, Accelerated Phase 41 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41 Hematologic Neoplasms 41 Lymphoma, Mantle-Cell 40 Lymphoma, Large B-Cell, Diffuse 40 Leukemia, Myelomonocytic, Chronic 39 Congenital Abnormalities 36 Burkitt Lymphoma 36 Lymphoma, B-Cell, Marginal Zone 35 Leukemia, Myeloid, Chronic-Phase 34 Primary Myelofibrosis 33 Blast Crisis 32 Neoplasms, Plasma Cell 31 Lymphoma, Large-Cell, Immunoblastic 29 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21 Waldenstrom Macroglobulinemia 20 Myelodysplastic-Myeloproliferative Diseases 20 Lymphoma, T-Cell, Cutaneous 20

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 3 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 cryoprecipitate coagulum 1 Tacrolimus 1 Surveys and Questionnaires 1 Specimen Handling 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Observation 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Ifosfamide 1 Gemcitabine 1 Floxuridine 1 Early Intervention, Educational 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡